companydata.dkcompanydata.dk

Signum Life Science ApS: Financial statements 2023

CVR: 36559241

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,482,298 and a net result of DKK -3,084,293 compared with DKK -11,313,396 the year before. Equity in the 2023 report amounted to DKK 112,748,108. The solvency ratio was 85.8%. The company had 41 employees in the financial year.

Gross Profit
DKK 1,482,298
Profit/Loss
DKK -3,084,293
Equity
DKK 112,748,108
Total Assets
DKK 131,454,468
Employees
41

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-1.5M-3.1M112.7M41
2022--184K-11.3M115.8M36
2021-7.6M1.3M128.5M34
2020-8.1M1M128.2M32
2019-10.5M3.8M129.2M28

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

DLI Market Intelligence ApS changes name to Signum Life Science ApSOct 31, 2023

On October 31, 2023, the company changed its name from DLI Market Intelligence ApS to Signum Life Science ApS.

Signum Life Science ApS: The 2022 annual report is outMay 11, 2023

Signum Life Science ApS has published its annual report for 2022. Gross profit came to DKK -183,840, and the net result was DKK -11,313,396.

Jonas Emil Steenvinkel leaves the board of Signum Life Science ApSApr 30, 2023

As of April 30, 2023, Jonas Emil Steenvinkel has left the board of directors of Signum Life Science ApS.

Mari-Ann Retz joins the board of Signum Life Science ApSApr 14, 2023

As of April 14, 2023, Mari-Ann Retz has joined the board of directors of Signum Life Science ApS.

Tore von Würden Petersen joins the board of Signum Life Science ApSApr 14, 2023

As of April 14, 2023, Tore von Würden Petersen has joined the board of directors of Signum Life Science ApS.

Lars Møller leaves the board of Signum Life Science ApSApr 14, 2023

As of April 14, 2023, Lars Møller has left the board of directors of Signum Life Science ApS.

Tore von Würden Petersen leaves the board of Signum Life Science ApSApr 13, 2023

As of April 13, 2023, Tore von Würden Petersen has left the board of directors of Signum Life Science ApS.

About Signum Life Science ApS

Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.

Source: annual report 2025, Danish Business Authority